January 10, 2017
Crosstex, a division of Cantel Medical Corp., is pleased to announce the recent hire of Mark Duro, who will join the team as Director of Clinical Education following the recent retirement of Chuck Hughes. With world-class education at the forefront of the company’s mission, Mr. Duro’s primary role will focus on providing continuing education experiences, assisting acute care facilities to comply with Joint Commission, CMS and AAMI standards and curriculum development for all Crosstex medical training programs.
“I was attracted by the company’s dedication to delivering innovative infection prevention products, services and solutions for patients, caregivers, and other healthcare providers,” Mr. Duro said. “I believe that teaching people how to apply infection prevention principles to healthcare, their facilities, and even their lives, is the best multiplier to truly create change.”
Mr. Duro has 26 years experience in the sterile processing field. Most recently, he was the Director of Sterile Processing Operations at New England Baptist Hospital in Boston, Massachusetts and the Vice President of the Massachusetts Chapter of Central Service professionals.
Mr. Duro has been a member of the International Association of Healthcare Central Service Materiel Management (IAHCSMM) since 1992 and is one of 34 Fellows within the organization. For the past six years, Mr. Duro has been an IAHCSMM-approved instructor, and in 2015 he was appointed to the IAHCSMM’s Executive Board. In 2016, Mr. Duro was named president-elect. Also, he has presented at more than 75 educational sessions at various chapter meetings and healthcare conferences throughout the US, Canada and abroad.
Jackie Beltrani, Vice President of Marketing, stated, “We are looking forward to Mark applying his experience and communication skills to develop and teach curriculum that will help our customers provide quality outcomes. Crosstex continues to strive for the highest level of patient safety through education, products and best practices.”
Crosstex, a Cantel Medical company, manufactures a wide array of unique and innovative infection prevention and compliance products for the global healthcare industry. Founded in 1953 and headquartered in Hauppauge, New York, Crosstex is a recognized leader for its portfolio of waterline treatment, biological monitoring, sterility assurance packaging and personal protection equipment (PPE). Sold in more than 100 countries, the range of products distributed to medical, dental and veterinary practices and facilities include our award winning (5 consecutive years) SECURE FIT® technology face masks, DENTAPURE® waterline treatment cartridges and LIQUID ULTRA™ waterline treatment, SURE-CHECK® sterilization pouches with internal/external multi-parameter indicators, Tyvek pouches with 510K approval, SteamPlus Type 5 chemical integrators, CONFIRM® and PASSPORT® Plus in-office and mail-in biological indicators, RAPICIDE® OPA/28 high level disinfectant.
For information on the full line of Crosstex infection prevention, patient safety and compliance products, please contact Crosstex at 631-582-6777 or visit www.crosstex.com.
About Cantel Medical
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.
For further information, visit the Cantel website at www.cantelmedical.com.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.